Interstitial lung disease in lysosomal storage disorders

R Borie, B Crestani, A Guyard… - European Respiratory …, 2021 - Eur Respiratory Soc
Lysosomes are intracellular organelles that are responsible for degrading and recycling
macromolecules. Lysosomal storage diseases (LSDs) are a group of inherited diseases …

[HTML][HTML] Clinical and biochemical footprints of inherited metabolic diseases. XIII. Respiratory manifestations

A Rossi, S Basilicata, M Borrelli, CR Ferreira… - Molecular Genetics and …, 2023 - Elsevier
At any age, respiratory manifestations are a major cause of increased morbidity and
mortality of inherited metabolic diseases (IMDs). Type and severity are extremely variable …

Consensus clinical management guidelines for acid sphingomyelinase deficiency (Niemann–Pick disease types A, B and A/B)

T Geberhiwot, M Wasserstein, S Wanninayake… - Orphanet Journal of …, 2023 - Springer
Abstract Background Acid Sphingomyelinase Deficiency (ASMD) is a rare autosomal
recessive disorder caused by mutations in the SMPD1 gene. This rarity contributes to …

Biochemical and imaging parameters in acid sphingomyelinase deficiency: Potential utility as biomarkers

ECB Eskes, B Sjouke, FM Vaz, SMI Goorden… - Molecular Genetics and …, 2020 - Elsevier
Abstract Acid Sphingomyelinase Deficiency (ASMD), or Niemann-Pick type A/B disease, is a
rare lipid storage disorder leading to accumulation of sphingomyelin and its precursors …

[HTML][HTML] Respiratory failure and sleep-disordered breathing in late-onset Pompe disease: a narrative review

NM Shah, L Sharma, S Ganeshamoorthy… - Journal of Thoracic …, 2020 - ncbi.nlm.nih.gov
Late-onset Pompe disease (LOPD) is a rare autosomal recessive glycogen storage disease
that results in accumulation of glycogen in muscle cells causing muscular weakness. It …

Channels and transporters of the pulmonary lamellar body in health and disease

P Dietl, M Frick - Cells, 2021 - mdpi.com
The lamellar body (LB) of the alveolar type II (ATII) cell is a lysosome-related organelle
(LRO) that contains surfactant, a complex mix of mainly lipids and specific surfactant …

Non-cardiac manifestations in adult patients with mucopolysaccharidosis

KM Stepien, A Bentley, C Chen… - Frontiers in …, 2022 - frontiersin.org
Mucopolysaccharidoses (MPS) are a heterogeneous group of disorders that results in the
absence or deficiency of lysosomal enzymes, leading to an inappropriate storage of …

Mucopolysaccharidosis III in Mainland China: natural history, clinical and molecular characteristics of 34 patients

W Kong, Y Meng, L Zou, G Yang, J Wang… - Journal of Pediatric …, 2020 - degruyter.com
Abstract Objectives Sanfilippo syndrome (Mucopolysaccharidosis III, MPS III) is a rare
autosomal recessive hereditary disease, which is caused by lysosomal enzyme deficiency …

Pulmonary manifestations in young Gaucher disease patients: phenotype‐genotype correlation and radiological findings

AA Gawad Tantawy, AA Moneam Adly… - Pediatric …, 2020 - Wiley Online Library
Background Although pulmonary involvement is important orbidity in Gaucher disease (GD),
it is previously reported to be rare. Moreover, no epidemiological studies described its …

Endolysosomal cation channels and lung disease

B Spix, A Jeridi, M Ansari, AÖ Yildirim, HB Schiller… - Cells, 2022 - mdpi.com
Endolysosomal cation channels are emerging as key players of endolysosomal function
such as endolysosomal trafficking, fusion/fission, lysosomal pH regulation, autophagy …